NCT02208271

Brief Summary

The purpose of the study is to develop a biomarker assay to be used as a diagnostic tool for adverse local tissue reaction, or tissue necrosis, in a metal on metal total hip replacement. A convenience sample of a total of 100 hip patients will be enrolled: 50 metal-on-metal revision hips, 25 metal-on-poly revision hips, and 25 pre-operative total hips (no implant, control group) will be enrolled. Preoperative blood serum samples and intraoperative synovial fluid will be obtained from all hips and used for biomarker testing. Additionally, intraoperative assessment of tissue necrosis will be assessed.

Trial Health

53
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial recruitment is currently suspended
Enrollment
174

participants targeted

Target at P50-P75 for all trials

Timeline
57mo left

Started Aug 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress72%
Aug 2014Dec 2030

First Submitted

Initial submission to the registry

July 17, 2014

Completed
18 days until next milestone

Study Start

First participant enrolled

August 4, 2014

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 5, 2014

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 17, 2018

Completed
12.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2030

Expected
Last Updated

April 30, 2025

Status Verified

April 1, 2025

Enrollment Period

3.8 years

First QC Date

July 17, 2014

Last Update Submit

April 25, 2025

Conditions

Keywords

tissue necrosismetal on metal total hipbiomarker

Outcome Measures

Primary Outcomes (1)

  • The number of patients with serum and synovial fluid biomarkers

    Blood Serum and Synovial fluid will be tested using a multi-analyte assay test

    participants will be followed for the duration of their hospital stay, an expected average of 2 hours

Secondary Outcomes (1)

  • The number of patients with tissue necrosis

    participants will be followed for the duration of their hospital stay, an expected average of 2 hours

Study Arms (3)

Control

pre-operative total hip patients with no existing total hip implant

Metal on polyethylene

patients who have a failed metal on polyethylene total hip implant and are presenting for revision surgery

Metal on Metal

patients who have a failed metal on metal total hip implant and are presenting for revision surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

A convenience sample of a total of 100 hip patients will be enrolled at orthopedic clinics.

You may qualify if:

  • Patients presenting for a metal on metal hip revision who have cobalt and chromium metal ion levels tested within 6 months of the date of the planned revision surgery.
  • Patients presenting for a metal on poly hip revision
  • Revision hip patients must be greater than one year postoperative
  • The diagnosis at the time of the index, or primary, hip replacement was osteoarthritis.
  • Patients who have hip osteoarthritis but have not had a total hip surgery (control)

You may not qualify if:

  • Patients presenting for a metal on metal hip revision who have cobalt and chromium metal ion levels tested \>6 months of the date of the planned revision
  • Patients with a total hip on the contralateral side.
  • Patients with a prior history of periprosthetic infection
  • Revision cases where the diagnosis at the time of the index, or primary, hip replacement was not osteoarthritis.
  • Prisoners
  • Patients not willing to consent for the proposed treatment
  • Patients with an altered mental status
  • Active, concurrent metastatic infection
  • Active, superficial infection
  • Patients presenting for a metal on poly hip revision to treat trunionosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

OrthoCarolina

Charlotte, North Carolina, 28207, United States

Location

Related Publications (9)

  • MacDonald SJ. Metal-on-metal total hip arthroplasty: the concerns. Clin Orthop Relat Res. 2004 Dec;(429):86-93. doi: 10.1097/01.blo.0000150309.48474.8b.

    PMID: 15577471BACKGROUND
  • Lindgren JU, Brismar BH, Wikstrom AC. Adverse reaction to metal release from a modular metal-on-polyethylene hip prosthesis. J Bone Joint Surg Br. 2011 Oct;93(10):1427-30. doi: 10.1302/0301-620X.93B10.27645.

    PMID: 21969447BACKGROUND
  • Lombardi AV Jr, Barrack RL, Berend KR, Cuckler JM, Jacobs JJ, Mont MA, Schmalzried TP. The Hip Society: algorithmic approach to diagnosis and management of metal-on-metal arthroplasty. J Bone Joint Surg Br. 2012 Nov;94(11 Suppl A):14-8. doi: 10.1302/0301-620X.94B11.30680.

    PMID: 23118373BACKGROUND
  • Cobb AG, Schmalzreid TP. The clinical significance of metal ion release from cobalt-chromium metal-on-metal hip joint arthroplasty. Proc Inst Mech Eng H. 2006 Feb;220(2):385-98. doi: 10.1243/09544119JEIM78.

    PMID: 16669404BACKGROUND
  • Mabilleau G, Kwon YM, Pandit H, Murray DW, Sabokbar A. Metal-on-metal hip resurfacing arthroplasty: a review of periprosthetic biological reactions. Acta Orthop. 2008 Dec;79(6):734-47. doi: 10.1080/17453670810016795.

    PMID: 19085489BACKGROUND
  • Tower SS. Arthroprosthetic cobaltism: neurological and cardiac manifestations in two patients with metal-on-metal arthroplasty: a case report. J Bone Joint Surg Am. 2010 Dec 1;92(17):2847-51. doi: 10.2106/JBJS.J.00125. Epub 2010 Oct 29. No abstract available.

    PMID: 21037026BACKGROUND
  • Campbell P, Ebramzadeh E, Nelson S, Takamura K, De Smet K, Amstutz HC. Histological features of pseudotumor-like tissues from metal-on-metal hips. Clin Orthop Relat Res. 2010 Sep;468(9):2321-7. doi: 10.1007/s11999-010-1372-y.

    PMID: 20458645BACKGROUND
  • Leopold SS, Berger RA, Patterson L, Skipor AK, Urban RM, Jacobs JJ. Serum titanium level for diagnosis of a failed, metal-backed patellar component. J Arthroplasty. 2000 Oct;15(7):938-43. doi: 10.1054/arth.2000.6632.

    PMID: 11061457BACKGROUND
  • Griffin WL, Fehring TK, Kudrna JC, Schmidt RH, Christie MJ, Odum SM, Dennos AC. Are metal ion levels a useful trigger for surgical intervention? J Arthroplasty. 2012 Sep;27(8 Suppl):32-6. doi: 10.1016/j.arth.2012.03.020. Epub 2012 May 17.

    PMID: 22608683BACKGROUND

MeSH Terms

Conditions

Arthritis

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal Diseases

Study Officials

  • Thomas Fehring, MD

    OrthoCarolina Research Institute, Inc.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 17, 2014

First Posted

August 5, 2014

Study Start

August 4, 2014

Primary Completion

May 17, 2018

Study Completion (Estimated)

December 31, 2030

Last Updated

April 30, 2025

Record last verified: 2025-04

Locations